Unique Informatics Technology Improves Workflow Flexibility and Data Integration
Seattle, WA – May 1, 2006 – Teranode Corporation, the leading innovator of scientific data and workflow management software for the Life Sciences industry, today announced the U.S. Patent and Trademark Office (PTO) has issued the company U.S. Patent No. 7,010,760 B2 for a key element of TERANODE XDA. The patent protects the method and apparatus for TERANODE XDA's match rules, a feature for integrating datasets and metadata in dynamic workflow. By automating critical data integration, the match rules enable scientists to quickly and reliably understand the provenance and relationships of data within projects.
Traditional informatics solutions depend on static, predefined schemas and workflows which are brittle and often break down when scientists need to make changes to the design of an experiment. TERANODE XDA accommodates change through an adaptive schema and workflow capability without requiring error-prone, manual data management procedures or expensive reprogramming.
"TERANODE XDA is the first product to integrate process metadata, schema metadata, and instrument data as part of a workflow," said Larry Arnstein, CTO of Teranode. "The match rules technology provides new flexibility in laboratory operations, while providing unrivaled data integration. Once captured, TERANODE XDA leverages semantic web standards to unlock the true potential of the data by enabling analysis, reporting, and search across projects and disciplines."
TERANODE XDA is a powerful informatics platform that leverages existing IT infrastructure to manage scientific data and workflow. TERANODE XDA allows scientists to automate workflow, manage the lifecycle of scientific data, and unify disparate data across laboratories, improving the speed and quality of R&D projects.
About Teranode Corporation
Teranode Corporation, a venture-backed company headquartered in Seattle, Washington, is the leading innovator of scientific data and workflow management software for the Life Sciences industry. Teranode's award-winning products are used by leading pharmaceutical, biotechnology, research, and academic organizations, including Pfizer, AstraZeneca, NIH Chemical Genomics Center, MIT, and Fred Hutchinson Cancer Research Center, to improve the speed and value of experimentation in R&D and then share chemical and biological knowledge enterprise-wide. For more information, visit www.teranode.com.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.